Latest News of RXST
RxSight, Inc. (NASDAQ:RXST) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
RxSight, Inc. recently reported Q3 results, with shares down 6%. Despite meeting revenue expectations, losses per share were lower than predicted. Analysts forecast a 47% revenue increase in 2025 and ...
RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now
A recent analysis compares RxSight, Inc. (NASDAQ:RXST) with other small-cap stocks, highlighting its advancements and growth prospects in the cataract surgery market. Wall Street predicts positive com...
Institutional investors control 71% of RxSight, Inc. (NASDAQ:RXST) and were rewarded last week after stock increased 6.0%
Institutions hold a 71% stake in RxSight, giving them significant influence over its share price. With a market cap of US$2.3b, institutional investors have benefited from the company's growth....
-
Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST)
By Yahoo! Finance | 5 months agoRxSight Inc develops innovative optical solutions for cataract surgery patients, with the Light Adjustable Lens as its flagship product. Insider transactions indicate more sales than purchases recentl...